NIH Awards Phase I SBIR to NanoInk for DNA Array Development | GenomeWeb

NEW YORK, Nov. 18 (GenomeWeb News) - NanoInk has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to support the development of its Dip Pen Nanolithography technology for miniaturizing DNA arrays, the company said today.

NanoInk said the grant is the first award of a two-phase $1.3 million award. Phase I SBIR's are generally in the $100,000 range.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.